May 24, 2023 / NTS GMT
Presentation
May 24, 2023 / NTS GMT
=====================
Corporate Participants
=====================
* Gary Phillips
Pharmaxis Ltd - CEO
=====================
Unidentified Participant
Good morning, everyone. The clock has now just pass 9:00 AM. So we will get started with a special investor briefing with Pharmaxis' CEO, Gary Phillips, who has some very exciting clinical data to be presented from Pharmaxis skin scarring trials freshly analyzed over at the University of Western Australia. My name is Alfred, and I'm part of Pharmaxis' Investor Relations team, and I'll assist with running today's briefing. (Event Instructions)
Having been in a trading hope for the past couple of days, while data was being finalized, it's been a very busy days for Pharmaxis. And I'm sure Gary is very excited to present this new data. So Gary, I won't take up any of -- more of your time. Let me hand over to you.
Gary Phillips - Pharmaxis Ltd - CEO
Thank you, Alfred, and good morning, everybody, and thanks for taking the time. I know
Pharmaxis Ltd Corporate Presentation Transcript
May 24, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers